Member Info for Midas3316

The time before last the FDA suggested that Iclaprim should not be developed further. Which was ignored, then went on to pass stage 3. No wait it didn’t pass stage 3 it Fai....... Not quite sure what other word I could use.

Is this a quiz or crossword game going on here. It didn’t pass stage 3 trial It F_ _ I_ D.

Yes. I know the link with Lamellar etc. Motif were expecting an independent director to be appointed as it was part of the wind down process. Maybe there is something in it.???

I don’t know. I’ve seen shares over the years multibag even after being told they were finished, to delist etc. Many well known recent ones. Debenhams as an example. Aiq was another that couldn’t be explained - a cash shell with 5p a share ( a BOD ) with a very shady past including companies forced to delist, yet people were paying 20x its value. All because people were just buying as others were buying. This will I believe result in an RTO here, but I don’t see anything to be made at this price. It hasn’t crashed back because people have still been buying this, not so much now. It could well stay around this price for sometime. It won’t drop just because no one is buying. The buys are roughly equal the sells, or if it remains quiet it will still remain around this price until maybe terms of a RTO are announced

Pmsl. If Motif or Iclaprim was so sought after by someone they should have started buying when the entire MCAP was only £250k a couple of months back.

And 20 ramping.

Lol. I’d research some more.

Trump. If you research it you will find it’s now over 20year history hasn’t been the best. Passed around with a lower value each time. Roche sold it on first over 20years back. So far it looks like they were right.

That’s what the other 6 owners of Iclaprim thought. Even after the FDA said they shouldn’t develop it any further, yet they did and failed stage 3 for the 3rd time

Pmsl. The usual answer from those that haven’t a clue.

Trumpton. What do you know about Iclaprim ?

That was meant to be Motif using Lamellasone. But it never got started and was shelved.

Trump. Motif was to start that trial. That’s in the past, they have no involvement with that now.

Log out and back again. BRB. LSE has an antiquated site.

I’ve followed this for a few years now, as I do with a lot of clinical stage companies. I don’t question how much of your pocket money you have in here. TBH. I rarely post comments on my main investments as quite often I’m involved with Clinical trials of these companies.

It’s an update from Lamellar that was known about months back. Just re-hyped links

* news

I’ve never said the share price would crash. Lamellar have been working on that for the last couple of months. Motif were doing a trial with Lamellar tec. Some time back but that was stopped. There has been the links with Lamellar but nothing new. Just re-ramped needs.

Not sure. But Batman is on the case.

It will probably level off now that the twitter readers have finished with their buying.